Description
Product Name: Depurin 40 tabs
Pharmaceutical Form: 40 tablets
Patient Information Leaflet:
Description
Indications:
Depurin is a dietary supplement rich in bioactive substances, indicated for a completing the diet in: hepatic diseases, hypo-acid gastritis, dyspepsia, malabsorption syndromes, gout, renal calculus, chronic urinary tract infections, edema, increases resistance to infectious diseases, fever, constipation (stimulates bowel movements), dyslipidemia, skin diseases (eczema, acne, furunculosis), general tonic.
The product is meant for persons of all ages – from pupils to retirees.
Contraindications:
The product is contraindicated during pregnancy and breastfeeding and for children up to 7 years old.
Precautions:
In case unwanted effects occur, discontinue the administration of the product and consult your doctor or pharmacist.
Ingredients:
Each tablet contains: 400 mg seabuckthorn total extract (Hippophae rhamnoides), 100 mg liquorice root extract (Glycyrrhiza glabra), 604 mg wild pansy extract (Viola tricolor), burdock root extract (Arctium lappa) and dandelion extract (Taraxacum officinale), excipients up to 1200mg.
Effects:
Depurin provides dietary intake of nutrients and bioactive substances, having the following effects: depurative, diuretic, diaphoretic, laxative, pancreatic secretion and hepatobiliary function stimulation, bitter tonic, detoxifying (stimulates the secretory and liver detoxification functions, enhances the elimination of toxins from the colon), antioxidant, immunomodulatory, anti-allergic, hypoglycemic, hypocholesterolemic and uricosuric.
Directions for Use:
The product is a dietary supplement and does not replace a varied and balanced diet.
Adults: take 2-3 tablets a day after meals, or according to the doctor` s advice.
Children between 7-14 years: take 1 tablet 1-2 times a day. After dilution, the alcohol concentration decreases to a homeopathic level and does not have contraindications related to its toxicity.
Manufacturer: HOFIGAL








Reviews
There are no reviews yet.